Advance in biologics for chronic rhinosinusitis with nasal polyps. [PDF]
Di Y, Zeng R, Huang L, Wu Y, Wu Q.
europepmc +1 more source
A Case Series of Tofacitinib Treatment for Chronic Spontaneous Urticaria with Inadequate Response to Omalizumab. [PDF]
Zhang X, Zhu M, Ye Y.
europepmc +1 more source
Medicaid Coverage and Utilization for Novel Therapies for Chronic Rhinosinusitis With Nasal Polyposis. [PDF]
Ramos ER +7 more
europepmc +1 more source
The identification of biomarkers for response to omalizumab in adult asthma based on untargeted metabolomic analysis. [PDF]
Li Y +5 more
europepmc +1 more source
The efficacy and safety of omalizumab in the treatment of asthma: an overview of systematic reviews and meta analyses. [PDF]
Li D +7 more
europepmc +1 more source
The Therapeutic Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Review of the Current Evidence. [PDF]
Chen W +5 more
europepmc +1 more source
Standardized pressure provocation as an objective clinical marker of omalizumab response in delayed pressure urticaria: an open-label, real-life, prospective cohort. [PDF]
Konstantinou GN, Podder I.
europepmc +1 more source
Omalizumab-Induced Remission and Steroid Withdrawal in Refractory Eosinophilic Gastroenteritis with Severe Hypereosinophilia: A Case Report. [PDF]
Du Z, Zhou W, Li J, Ma L, Zhu Q, Zhi Y.
europepmc +1 more source
Clinical Remission in Severe T2-High Asthma in Real Life After Anti-IgE, Anti-IL-5 and Anti-IL5R: A Potential Role for CRP as a Biomarker. [PDF]
Vervier J +12 more
europepmc +1 more source

